TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3904805

Group type: EXPERIMENTAL
Intervention: Tigason at half of the maximal dose tolerated during the clearing phase of the treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tigason
Number of subjects: 36
Study: 31401675

Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise training (HIIT)
Number of subjects: 52
Study: 30539170

Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis (CADx) using CMDfact 4 functional diagnostics software
Number of subjects: 39

Group type: COMPARATOR
Intervention: Traditional diagnostic methods (TRAD)
Number of subjects: 39
Study: 27586548

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) 3000 mg/day with weight loss diet and 400 IU vitamin E
Number of subjects: 38
Study: 24698514

Group type: EXPERIMENTAL
Intervention: Calcineurin inhibitor toxicity (CNIT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Normal allografts (control)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Progressors to CAD
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Nonprogressors to CAD
Number of subjects: 55
Study: 22327091

Group type: EXPERIMENTAL
Intervention: Whole-body vibration therapy (12 weeks, 12.5 Hz frequency and 3 mm amplitude)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (standard care including medical care and social support)
Number of subjects: 41
Study: 20935080

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 18830038

Group type: EXPERIMENTAL
Intervention: Once-weekly treatment with 17.5 mg risedronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Once-daily treatment with 2.5 mg risedronate
Number of subjects: 0
Study: 15716168

Group type: EXPERIMENTAL
Intervention: Cued covert orienting with exogenous cues (luminance change in a peripheral box)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cued covert orienting with endogenous cues (central arrow)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cued covert orienting with endogenous cues (central word)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (typically developing children)
Number of subjects: 132
Study: 11833749

Group type: EXPERIMENTAL
Intervention: LCT
Number of subjects: 83

Group type: COMPARATOR
Intervention: MCT/LCT
Number of subjects: 83
Study: 10517170

Group type: EXPERIMENTAL
Intervention: Surgery during the follicular phase (days 0-14)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Surgery during the luteal phase (days 15-32)
Number of subjects: 248
Study: 8559485

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (500 micrograms thrice weekly for 3 months, then 200 micrograms thrice weekly for the next 3 months)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1780077

Group type: EXPERIMENTAL
Intervention: Dipyridamole (200 mg b.i.d.) combined with low-dose aspirin (25 mg b.i.d.)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 6358451

Group type: EXPERIMENTAL
Intervention: Conventional periodontal treatment with adjunctive metronidazole therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional periodontal treatment without adjunctive metronidazole therapy (placebo)
Number of subjects: 0
Study: 31074484

Group type: EXPERIMENTAL
Intervention: Biobehavioral therapy with orthopedic manual physical therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Biobehavioral therapy only
Number of subjects: 50
Study: 29475737

Group type: EXPERIMENTAL
Intervention: ADT+D (Docetaxel) for high-volume disease
Number of subjects: 1175

Group type: COMPARATOR
Intervention: ADT alone for low-volume disease
Number of subjects: 1175
Study: 26467373

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg orally for 2 weeks before and 12 weeks after surgery)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metoprolol (50 mg orally for 2 weeks before and 12 weeks after surgery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All patients (combined data)
Number of subjects: 60
Study: 25345429

Group type: EXPERIMENTAL
Intervention: PDT-1 (600 mg thioctic acid)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PDT-2 (600 mg thioctic acid)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Reference (Thioctacid® HR)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: PDT-2
Number of subjects: 72
Study: 22851967

Group type: EXPERIMENTAL
Intervention: Medial branch blocks with local anesthetic alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Medial branch blocks with local anesthetic and steroids
Number of subjects: 100
Study: 20136553

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE)
Number of subjects: 6461

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 6461

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 6461

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6461
Study: 17257477

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (75-325 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other antiplatelet agents (e.g., clopidogrel)
Number of subjects: 0
Study: 15797227

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 12480784

Group type: EXPERIMENTAL
Intervention: Hyperintense lesions (HL) in subcortical gray matter (thalamus and caudate) and associated white matter tracts (internal/external capsule)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Hyperintense lesions (HL) in both gray and white matter
Number of subjects: 154
Study: 9653409

Group type: EXPERIMENTAL
Intervention: Experimental group (residents who participated in the teaching skills course)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (residents who did not participate in the teaching skills course)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study: 8129609

Group type: EXPERIMENTAL
Intervention: Ranitidine hydrochloride (100 mg) administered twice a day intravenously for 4 days, followed by oral ranitidine hydrochloride (150 mg) administered twice a day for 5 days (n = 11)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No adjuvant treatment (n = 13)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control patients (n = 13)
Number of subjects: 24
Study: 2697240

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiopental/Isuflurane
Number of subjects: 60
Study: 4609532

Group type: EXPERIMENTAL
Intervention: 250 mg of marihuana sample B
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 500 mg of marihuana sample A
Number of subjects: 33

Group type: COMPARATOR
Intervention: 500 mg of marihuana sample C
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Delta(9)-THC administered to human subjects and laboratory animals
Number of subjects: 33
Study: 30540353

Group type: EXPERIMENTAL
Intervention: Successful discontinuation of antipsychotic medication regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27588891

Group type: EXPERIMENTAL
Intervention: Physical Training and Nutrition (PTN) group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Social Support (SOSU) group
Number of subjects: 80
Study: 25223963

Group type: EXPERIMENTAL
Intervention: Self-paced exercise (n=30)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Moderate intensity exercise (n=29)
Number of subjects: 59
Study: 24103648

Group type: EXPERIMENTAL
Intervention: Evidence-based quality improvement plus facilitation intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 12
Study: 22128655

Group type: EXPERIMENTAL
Intervention: U.S. Navy Sexual Assault Intervention Training (SAIT) program
Number of subjects: 550

Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 550
Study: 19780737

Group type: EXPERIMENTAL
Intervention: Cryotherapy with compressed carbon dioxide through a cryoprobe placed on the cervix
Number of subjects: 85

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 85
Study: 16427211

Group type: EXPERIMENTAL
Intervention: Salvage hormone therapy (HT) initiated after initial treatment
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Salvage hormone therapy (HT) for patients with DM absent
Number of subjects: 247
Study: 15562184

Group type: EXPERIMENTAL
Intervention: Modified low fat diet inclusive of 30 g of walnuts per day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Modified low fat diet
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low fat diet
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Walnut group
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 58
Study: 11743411

Group type: EXPERIMENTAL
Intervention: Smooth saline-filled prosthesis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Textured saline-filled prosthesis
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall patient satisfaction
Number of subjects: 20
Study: 9402166

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with hematopoietic progenitor cell support (doxorubicin 75 mg/m2, cyclophosphamide 6000 mg/m2, etoposide 800 mg/m2, carboplatin 900 mg/m2, G-CSF 5 microg/kg/d)
Number of subjects: 30
Study: 8517510

Group type: EXPERIMENTAL
Intervention: High-dose adrenaline (10 mg every five minutes)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard dose of adrenaline (1 mg every five minutes)
Number of subjects: 40
Study: 3318052

Group type: EXPERIMENTAL
Intervention: Phenothiazine (thiethylperazine)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Combination of thiethylperazine and antihistaminic (diphenhydramine)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Combination of thiethylperazine and tricyclic antidepressant (amitriptyline)
Number of subjects: 132
Study: 29444618

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Iloperidone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 29489103

Group type: EXPERIMENTAL
Intervention: Combined spinal-paravertebral anesthesia (KSPA)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Combined spinal-epidural anesthesia (CSEA)
Number of subjects: 67
Study: 24719063

Group type: EXPERIMENTAL
Intervention: Topical liposomal Rose Bengal (LRB) gel followed by intense pulsed light (IPL) treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo gel followed by intense pulsed light (IPL) treatment
Number of subjects: 15
Study: 22388466

Group type: EXPERIMENTAL
Intervention: Ziprasidone (35 mg/d)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Clozapine (32.14 mg/d)
Number of subjects: 16
Study: 20167436

Group type: EXPERIMENTAL
Intervention: Follicular phase quitters with higher levels of Anger
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Follicular phase quitters with higher levels of Craving
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Luteal phase quitters
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Overall withdrawal symptoms (regardless of quit phase)
Number of subjects: 202
Study: 18206285

Group type: EXPERIMENTAL
Intervention: Less computationally complex physical identity task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: More complex adding task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blocked condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixed condition
Number of subjects: 0
Study: 15775946

Group type: EXPERIMENTAL
Intervention: Deciduous molar anchorage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mixed deciduous molar and premolar anchorage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Premolar anchorage
Number of subjects: 30
Study: 12519461

Group type: EXPERIMENTAL
Intervention: 10 mg haloxazolam (HAX)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 4 mg flunitrazepam (FNZ)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam (TRI)
Number of subjects: 17
Study: 10653869

Group type: EXPERIMENTAL
Intervention: Allogeneic blood cell transplantation (BCT)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Allogeneic bone marrow transplantation (BMT)
Number of subjects: 111
Study: 8678464

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine in active ulcerative colitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mucus layer thickness measurements
Number of subjects: 0
Study: 1847796

Group type: EXPERIMENTAL
Intervention: Intravenous cefoxitin, 1 g every 6 hours for 5 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 40
Study: 6339024

Group type: EXPERIMENTAL
Intervention: DTIC and BCG
Number of subjects: 94

Group type: COMPARATOR
Intervention: Careful observation
Number of subjects: 94
Study: 31269780

Group type: EXPERIMENTAL
Intervention: Acute moderate-intensity treadmill exercise (15 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Seated task (control)
Number of subjects: 40
Study: 28213188

Group type: EXPERIMENTAL
Intervention: MPH+RISP (1mg/kg/d+0.5mg/d)
Number of subjects: 84

Group type: COMPARATOR
Intervention: MPH+PLCO (1mg/kg/d+placebo)
Number of subjects: 84
Study: 26426270

Group type: EXPERIMENTAL
Intervention: Deworming at 12 months and placebo at 18 months
Number of subjects: 1760

Group type: EXPERIMENTAL
Intervention: Placebo at 12 months and deworming at 18 months
Number of subjects: 1760

Group type: EXPERIMENTAL
Intervention: Deworming at both 12 and 18 months
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Placebo at both 12 and 18 months
Number of subjects: 1760
Study: 23960104

Group type: EXPERIMENTAL
Intervention: Persuasive communication intervention (PCI)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Graded task intervention (GTI)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 21778332

Group type: EXPERIMENTAL
Intervention: Slow skin cooling (≈2°C/h)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Medium skin cooling (≈4°C/h)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Fast skin cooling (≈6°C/h)
Number of subjects: 11
Study: 18639221

Group type: EXPERIMENTAL
Intervention: Bascom's simple surgery
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cleft closure
Number of subjects: 55
Study: 17990451

Group type: EXPERIMENTAL
Intervention: Quxie Capsule (QXC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 44
Study: 15069559

Group type: EXPERIMENTAL
Intervention: Expert pianists
Number of subjects: 2

Group type: COMPARATOR
Intervention: Non-musicians
Number of subjects: 2
Study: 12150227

Group type: EXPERIMENTAL
Intervention: Performance-contingent consequences with positive mood
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncontingent consequences
Number of subjects: 0
Study: 10456306

Group type: EXPERIMENTAL
Intervention: Gray-scale ultrasonography
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Color and pulsed Doppler ultrasonography
Number of subjects: 45
Study: 7761738

Group type: EXPERIMENTAL
Intervention: Timed exposure to bright light (4‐7,000 lux between 2400 and 0400 hours on each of three night shifts)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous melatonin (2 mg at 0800 hours, then 1 mg at 1100 and 1400 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (dim red light at less than 50 lux or placebo sucrose capsules)
Number of subjects: 0
Study: 2104084

Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms, single subcutaneous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 0
Study: 534419

Group type: EXPERIMENTAL
Intervention: Lecithin plus physostigmine
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lecithin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Physostigmine without lecithin
Number of subjects: 5
Study: 31697802

Group type: EXPERIMENTAL
Intervention: Localized-stage FL
Number of subjects: 666

Group type: COMPARATOR
Intervention: Advanced-stage FL
Number of subjects: 666
Study: 31097088

Group type: EXPERIMENTAL
Intervention: Oral metronomic vinorelbine (OMV) 50 mg three-times weekly
Number of subjects: 120

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 120
Study: 29759622

Group type: EXPERIMENTAL
Intervention: Pace-guided group (PG)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional group (PVI)
Number of subjects: 74
Study: 25862833

Group type: EXPERIMENTAL
Intervention: Ozone exposure (100 ppb)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ozone exposure (200 ppb)
Number of subjects: 26
Study: 23419077

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Acceptance and commitment therapy
Number of subjects: 84
Study: 21254886

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Ustekinumab 90 mg
Number of subjects: 603

Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 603
Study: 19726290

Group type: EXPERIMENTAL
Intervention: Remifentanil preconditioning (5 microg/kg in 50 ml normal saline)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (normal saline only)
Number of subjects: 24
Study: 16406153

Group type: COMPARATOR
Intervention: Memory activation during picture memory task
Number of subjects: 12

Group type: COMPARATOR
Intervention: Memory activation during word memory task
Number of subjects: 12
Study: 15771036

Group type: EXPERIMENTAL
Intervention: FastTrack rehabilitation program with epidural analgesia, short laparotomy, early feeding and mobilisation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: FastTrack rehabilitation program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual postoperative treatment with a pain control program
Number of subjects: 40
Study: 11239652

Group type: EXPERIMENTAL
Intervention: Radially expanding access device
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional cutting-tip trocar
Number of subjects: 34
Study: 9929658

Group type: EXPERIMENTAL
Intervention: Common cold (acute rhinitis)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Oxymetazoline (to control mucus secretion)
Number of subjects: 36
Study: 7520904

Group type: EXPERIMENTAL
Intervention: Risperidone 2 mg/day
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Risperidone 6 mg/day
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Risperidone 10 mg/day
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Risperidone 16 mg/day
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Haloperidol 20 mg/day
Number of subjects: 513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study: 2737236

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg daily for 14 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Diclofenac Na 100 mg daily for 14 days
Number of subjects: 36
Study: 1102233

Group type: EXPERIMENTAL
Intervention: Benzquinamide, 100 mg 3 times daily
Number of subjects: 183

Group type: COMPARATOR
Intervention: Prochlorperazine, 10 mg 3 times daily
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Benzquinamide
Number of subjects: 183
Study: 31402006

Group type: EXPERIMENTAL
Intervention: T2 (LNS for children aged 6-18 months)
Number of subjects: 3738

Group type: EXPERIMENTAL
Intervention: T3 (LNS for pregnant or lactating women)
Number of subjects: 3738

Group type: COMPARATOR
Intervention: T0 (standard-of-care programme)
Number of subjects: 3738
Study: 28723831

Group type: COMPARATOR
Intervention: Intrathecal bupivacaine 2.5 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 5.0 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 7.5 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 10.0 mg
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 7.5 mg or higher
Number of subjects: 240
Study: 26627641

Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 247

Group type: COMPARATOR
Intervention: gp100 peptide vaccine
Number of subjects: 247
Study: 22744302

Group type: COMPARATOR
Intervention: HL-90%
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pmax - bw
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pmax + bw
Number of subjects: 43

Group type: COMPARATOR
Intervention: C
Number of subjects: 43
Study: 21950130

Group type: EXPERIMENTAL
Intervention: Psychological tests aimed to elucidate situational and personal anxiety, aggressiveness and hostility.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement of body mass index, activity of sympathetic nervous system, serum leptin level.
Number of subjects: 0
Study: 19452100

Group type: EXPERIMENTAL
Intervention: ETN + MTX + GCs (prednisone)
Number of subjects: 69

Group type: COMPARATOR
Intervention: ETN + MTX
Number of subjects: 69
Study: 16522653

Group type: EXPERIMENTAL
Intervention: Guidelines-based intervention (early contact of absentees; addressing psychosocial obstacles; offering temporary modified work; communicating among the players)
Number of subjects: 2918

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2918
Study: 14562564

Group type: EXPERIMENTAL
Intervention: Prophylactic antifibrinolytic therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11090726

Group type: EXPERIMENTAL
Intervention: Controlled hypotension with acute normovolemic hemodilution (ANH)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Controlled hypotension with acute hypervolemic hemodilution (HHD)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Controlled hypotension with prostaglandin E1 (PGE1)
Number of subjects: 28